Stocks and Investing Stocks and Investing
Wed, July 22, 2020
Tue, July 21, 2020
Mon, July 20, 2020
Sun, July 19, 2020
Fri, July 17, 2020

David Lewis Maintained (ABT) at Buy with Increased Target to $106 on, Jul 17th, 2020


Published on 2024-10-27 09:50:25 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $100 to $106 on, Jul 17th, 2020.

David has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with David


  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $122 on, Friday, July 10th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $113 on, Friday, April 17th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $108 on, Friday, April 17th, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $102 on, Friday, April 17th, 2020
  • Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $101 on, Thursday, April 16th, 2020